Medchem International Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 14-12-2024
- Paid Up Capital ₹ 2.50 Cr
as on 14-12-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 60.00 K
as on 14-12-2024
- Satisfied Charges ₹ 7.63 Cr
as on 14-12-2024
- Revenue -16.39%
(FY 2022)
- Profit -213.63%
(FY 2022)
- Ebitda -117.01%
(FY 2022)
- Net Worth -33.11%
(FY 2022)
- Total Assets 32.73%
(FY 2022)
About Medchem International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹60,000.00. The company has closed loans amounting to ₹7.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
Veera Tadikonda, Ratnakar Tadikonda, and Prabhakar Tadikonda serve as directors at the Company.
- CIN/LLPIN
U24230TG2006PLC049813
- Company No.
049813
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medchem International Limited offer?
Medchem International Limited offers a wide range of products and services, including Malaria Medicine, Antibiotic Tablets & Capsules, Cipla Antibiotic Drugs, Anti Infective Drugs & Medicines, HIV Drugs.
Who are the key members and board of directors at Medchem International?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veera Tadikonda  | Director | 13-Apr-2006 | Current |
| Ratnakar Tadikonda | Director | 14-Feb-2011 | Current |
| Prabhakar Tadikonda | Director | 11-Jun-2011 | Current |
Financial Performance of Medchem International.
Medchem International Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.39% decrease. The company also saw a substantial fall in profitability, with a 213.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medchem International?
In 2022, Medchem International had a promoter holding of 86.86% and a public holding of 13.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 26 Jun 2020 | ₹0.06 M | Open |
Jm Financial Asset Reconstruction Company Private Limited Creation Date: 19 Jan 2009 | ₹3.50 M | Satisfied |
Jm Financial Asset Reconstruction Company Private Limited Creation Date: 25 Aug 2006 | ₹7.28 Cr | Satisfied |
How Many Employees Work at Medchem International?
Medchem International has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medchem International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medchem International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
